Effect of maternal body mass index on in vitro response to tocolytics in term myometrium

Giuseppe Chiossi, Maged M. Costantine, Ancizar Betancourt, Gary D.V. Hankins, Monica Longo, George R. Saade, Egle Bytautiene

Research output: Contribution to journalArticlepeer-review

6 Scopus citations


Objective: We sought to investigate the effect of body mass index (BMI) on in vitro response to tocolytics. Study Design: Myometrial biopsies were obtained at the time of scheduled cesarean deliveries from term nonlaboring women with BMI ≤29.9 (26.3 ± 1.3; n = 7), 30-34.9 (31.8 ± 1.2; n = 16), and ≥35 (39.5 ± 4.9; n = 9). Tissue strips were suspended in organ chambers for isometric tension recording. The effects of cumulative doses (10-10 to 10-5 mol/L) of nifedipine or indomethacin on spontaneous uterine contractility were determined. Areas under the contraction curve were compared using 1-way analysis of variance with Tukey post hoc test. Results: Myometrial response to tocolytics did not differ between the BMI groups. Nifedipine, but not indomethacin, significantly inhibited myometrial contractility independent of BMI. Conclusion: BMI does not affect uterine response to tocolytics in isolated uterine tissue from term nonlaboring women.

Original languageEnglish (US)
Pages (from-to)261.e1-261.e5
JournalAmerican Journal of Obstetrics and Gynecology
Issue number3
StatePublished - Sep 2010


  • indomethacin
  • nifedipine
  • obesity
  • organ chamber
  • oxytocin
  • uterine contractility

ASJC Scopus subject areas

  • Obstetrics and Gynecology


Dive into the research topics of 'Effect of maternal body mass index on in vitro response to tocolytics in term myometrium'. Together they form a unique fingerprint.

Cite this